LMHRA Approves First Pharmaceutical Manufacturing Company

The Liberia Medicines and Health Products Regulatory Authority (LMHRA) has officially approved Liberia's first Pharmaceutical Manufacturing Company.

The Managing Director of LMHRA, Pharm. Keturah Smith-Chineh signed the Manufacturing License and Good Manufacturing Practice (GMP) Certificate of ‘Global Pharmaceuticals Manufacturing and Laboratories Limited’ for the manufacture of medicines in Liberia.

The issuance of the license was preceded by preliminary analytical testing of the first batch of medicines produced at the LMHRA’s Quality Control Laboratory; while confirmatory testing was also conducted in Ghana, at the United States Pharmacopeia Laboratory.  

USAID-PQM+ provided technical support during the process leading to the issuance of the license.

Making remarks shortly after the official signing ceremony at the head office of the authority, Managing Director Smith-Chineh said the LMHRA looks forward to the Company’s maintenance of the standards under which the company has been approved and a continual improvement in the Company's Quality Management Systems as well as the Company's continuous cooperation with LMHRA.   

According to her, the LMHRA will continue to ensure that only quality, safe and efficacious medicines are available within our pharmaceutical commerce.

The Liberia Medicines & Health Products Regulatory Authority (LMHRA) is the statutory arm of the Government of Liberia with the responsibility to ensure that all medicines and health products circulating the borders of Liberia are safe and efficacious.